Tags : Hubrecht Organoid Technology

Biotech

Cellesce Signs a License Agreement with Hubrecht Organoid Technology (HUB)

Shots: Cellesce & Hubrecht Organoid Technology (HUB) enters into an agreement for the expansion of breast organoids utilizing bioprocessing technology and HUB’s Organoid Technology at large scale The focus of the agreement is to develop genetically and phenotypically stable breast cancer organoids which retains the characteristics of tumors for drug discovery programmes HUB’s Organoid Technology […]Read More